ACRIS

Found in: Australia

Active ingredients

#
Active Ingredient
Description
1

Risedronic acid is a pyridinyl bisphosphonate that binds to bone hydroxyapatite and inhibits osteoclast-mediated bone resorption. The bone turnover is reduced while the osteoblast activity and bone mineralisation is preserved.

Medicine classification

ATC Code
Title
Class
Risedronic acid
M Musculo-skeletal system → M05 Drugs for treatment of bone diseases → M05B Drugs affecting bone structure and mineralization → M05BA Bisphosphonates

Identifiers

Authority
Identifier(s)
Pharmaceutical Benefits Scheme (AU)
Identifier(s): 4444X, 8621R, 9391G